Diabetic Life Insurance
Related Sites
Network Sites

Liraglutide May Enable Weight Loss Amongst Obese People

Tue, 27 Oct 2009

Recent research affirms that Type 2 diabetes drug Liraglutide may enable weight loss in obese people who are not suffering from diabetes .

The study monitored the impact Liraglutide has on bodyweight in obese people who have not got Type 2 diabetes.

This research was undertaken in 19 locations across Europe; 564 people participated, aged between 18 and 65 years with a BMI of between 30 and 40.

The participants adhered to a calorie-restricted diet and upped their physical activity as the trial progressed.

The study uncovered that participants on Liraglutide experienced more weight loss than those who were taking a placebo or the weight-loss drug Orlistat.

The findings established that Liraglutide increases the choice of treatments for Type 2 diabetics as it offers improved blood glucose control as well as weight loss.

Further research is needed to confirm the above findings.